Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tumor Suppressor Proteins | 23 | 2016 | 2804 | 2.020 |
Why?
|
Camptothecin | 3 | 2024 | 589 | 1.500 |
Why?
|
Phosphoproteins | 10 | 2016 | 2441 | 1.440 |
Why?
|
Carcinoma, Squamous Cell | 14 | 2018 | 4030 | 1.410 |
Why?
|
Transcription Factors | 29 | 2020 | 12106 | 1.370 |
Why?
|
Trans-Activators | 13 | 2014 | 2857 | 1.360 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 2925 | 1.300 |
Why?
|
BRCA2 Protein | 8 | 2020 | 797 | 1.280 |
Why?
|
Immunoconjugates | 4 | 2024 | 881 | 1.240 |
Why?
|
Breast Neoplasms | 36 | 2024 | 21019 | 1.210 |
Why?
|
BRCA1 Protein | 11 | 2024 | 1146 | 1.090 |
Why?
|
DNA-Binding Proteins | 19 | 2016 | 9587 | 0.970 |
Why?
|
Cisplatin | 7 | 2015 | 1643 | 0.920 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2024 | 74 | 0.920 |
Why?
|
Nuclear Proteins | 12 | 2011 | 5793 | 0.840 |
Why?
|
ras Proteins | 4 | 2020 | 1052 | 0.840 |
Why?
|
Head and Neck Neoplasms | 6 | 2021 | 2891 | 0.770 |
Why?
|
Genes, Neoplasm | 3 | 2017 | 370 | 0.670 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2020 | 3616 | 0.640 |
Why?
|
Drug Resistance, Neoplasm | 8 | 2023 | 5214 | 0.630 |
Why?
|
Cell Line, Tumor | 19 | 2024 | 16878 | 0.630 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 642 | 0.620 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 475 | 0.610 |
Why?
|
Protein Kinases | 7 | 2008 | 1612 | 0.600 |
Why?
|
Reactive Oxygen Species | 3 | 2015 | 2134 | 0.600 |
Why?
|
Haploinsufficiency | 1 | 2020 | 329 | 0.600 |
Why?
|
Genes, Tumor Suppressor | 5 | 2006 | 1056 | 0.590 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 8 | 2019 | 894 | 0.580 |
Why?
|
Ovarian Neoplasms | 4 | 2016 | 4871 | 0.580 |
Why?
|
Membrane Proteins | 8 | 2016 | 7838 | 0.540 |
Why?
|
Gene Fusion | 2 | 2021 | 351 | 0.530 |
Why?
|
Genetic Testing | 5 | 2015 | 3531 | 0.510 |
Why?
|
Genes, p53 | 5 | 2011 | 714 | 0.500 |
Why?
|
Adult Stem Cells | 2 | 2014 | 221 | 0.490 |
Why?
|
DNA Mutational Analysis | 5 | 2020 | 4111 | 0.480 |
Why?
|
Mutation | 27 | 2023 | 29878 | 0.480 |
Why?
|
DNA Damage | 4 | 2020 | 2442 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 17 | 2019 | 8489 | 0.460 |
Why?
|
Thioredoxins | 1 | 2015 | 201 | 0.450 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2024 | 11656 | 0.440 |
Why?
|
Carboplatin | 2 | 2021 | 789 | 0.430 |
Why?
|
Apoptosis | 10 | 2019 | 9470 | 0.430 |
Why?
|
Neuregulin-1 | 1 | 2014 | 135 | 0.430 |
Why?
|
Epithelial Cells | 5 | 2014 | 3664 | 0.410 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 549 | 0.410 |
Why?
|
Wilms Tumor | 3 | 2013 | 376 | 0.410 |
Why?
|
Nitrophenols | 1 | 2012 | 169 | 0.410 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1902 | 0.410 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 206 | 0.400 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2016 | 728 | 0.380 |
Why?
|
Lactation | 1 | 2014 | 395 | 0.380 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2016 | 2897 | 0.380 |
Why?
|
F-Box Proteins | 1 | 2012 | 202 | 0.380 |
Why?
|
Histone Deacetylase 2 | 1 | 2011 | 72 | 0.370 |
Why?
|
Neoplasms | 10 | 2024 | 22023 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 10 | 2019 | 2062 | 0.370 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2015 | 2866 | 0.370 |
Why?
|
Germ-Line Mutation | 7 | 2021 | 1843 | 0.360 |
Why?
|
Mice | 34 | 2022 | 80993 | 0.360 |
Why?
|
Histone Deacetylase 1 | 1 | 2011 | 134 | 0.360 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1405 | 0.350 |
Why?
|
Cell Survival | 4 | 2011 | 5793 | 0.350 |
Why?
|
Antineoplastic Agents | 9 | 2017 | 13625 | 0.340 |
Why?
|
Protein Isoforms | 8 | 2016 | 1695 | 0.340 |
Why?
|
Cell Hypoxia | 2 | 2012 | 657 | 0.330 |
Why?
|
Immunoprecipitation | 1 | 2012 | 878 | 0.330 |
Why?
|
Actins | 1 | 2016 | 2049 | 0.330 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 620 | 0.330 |
Why?
|
Wound Healing | 2 | 2017 | 2781 | 0.330 |
Why?
|
Transcriptional Activation | 6 | 2016 | 1756 | 0.320 |
Why?
|
Proteins | 6 | 2012 | 6024 | 0.320 |
Why?
|
Immunoblotting | 1 | 2012 | 1649 | 0.310 |
Why?
|
Animals | 41 | 2022 | 167531 | 0.310 |
Why?
|
Humans | 101 | 2024 | 759098 | 0.310 |
Why?
|
Histone Deacetylases | 1 | 2012 | 718 | 0.310 |
Why?
|
Heterozygote | 5 | 2020 | 2796 | 0.300 |
Why?
|
Biphenyl Compounds | 1 | 2012 | 987 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 9 | 2020 | 17748 | 0.300 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4883 | 0.300 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 772 | 0.290 |
Why?
|
Keratinocytes | 3 | 2006 | 792 | 0.290 |
Why?
|
Mice, Nude | 5 | 2019 | 3602 | 0.290 |
Why?
|
MicroRNAs | 3 | 2016 | 3797 | 0.280 |
Why?
|
Loss of Heterozygosity | 2 | 2022 | 659 | 0.280 |
Why?
|
Autophagy | 1 | 2015 | 1336 | 0.280 |
Why?
|
Receptors, Notch | 1 | 2011 | 743 | 0.280 |
Why?
|
Cell Adhesion Molecules | 2 | 2024 | 1599 | 0.280 |
Why?
|
Antigens, Neoplasm | 3 | 2024 | 2000 | 0.280 |
Why?
|
Estrogen Receptor alpha | 3 | 2023 | 580 | 0.270 |
Why?
|
Tumor Cells, Cultured | 11 | 2019 | 6132 | 0.260 |
Why?
|
Energy Metabolism | 3 | 2020 | 2869 | 0.260 |
Why?
|
WT1 Proteins | 3 | 2002 | 184 | 0.250 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5312 | 0.240 |
Why?
|
Pulmonary Emphysema | 1 | 2010 | 687 | 0.240 |
Why?
|
Neoplasms, Experimental | 1 | 2010 | 1230 | 0.240 |
Why?
|
Oxidative Stress | 4 | 2015 | 3105 | 0.240 |
Why?
|
Female | 56 | 2024 | 390174 | 0.240 |
Why?
|
Phthalazines | 2 | 2024 | 377 | 0.230 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2024 | 108 | 0.230 |
Why?
|
Receptors, Estrogen | 5 | 2019 | 2201 | 0.220 |
Why?
|
Genes, BRCA1 | 6 | 2017 | 769 | 0.220 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2012 | 1892 | 0.220 |
Why?
|
Transcription, Genetic | 8 | 2013 | 7593 | 0.220 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2014 | 921 | 0.210 |
Why?
|
Sulfonamides | 1 | 2012 | 1972 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2021 | 3584 | 0.210 |
Why?
|
Signal Transduction | 13 | 2018 | 23328 | 0.210 |
Why?
|
Cell Cycle Proteins | 2 | 2014 | 3449 | 0.200 |
Why?
|
Paracrine Communication | 2 | 2014 | 277 | 0.200 |
Why?
|
Neoplasm Proteins | 4 | 2017 | 3614 | 0.200 |
Why?
|
Carrier Proteins | 1 | 2015 | 4938 | 0.200 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5801 | 0.190 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5790 | 0.180 |
Why?
|
Mice, Knockout | 9 | 2021 | 14333 | 0.180 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 2824 | 0.180 |
Why?
|
Indazoles | 1 | 2022 | 302 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2006 | 2982 | 0.180 |
Why?
|
Cell Proliferation | 8 | 2019 | 10427 | 0.180 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2347 | 0.170 |
Why?
|
Xenopus Proteins | 1 | 2002 | 434 | 0.170 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2023 | 556 | 0.170 |
Why?
|
Mammary Glands, Animal | 2 | 2014 | 265 | 0.170 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2567 | 0.170 |
Why?
|
HEK293 Cells | 3 | 2020 | 4263 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2011 | 0.160 |
Why?
|
Ribosomal Protein S6 Kinases | 2 | 2017 | 203 | 0.160 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2020 | 259 | 0.160 |
Why?
|
Glycolysis | 2 | 2021 | 828 | 0.150 |
Why?
|
RNA Interference | 5 | 2020 | 2848 | 0.150 |
Why?
|
Feedback, Physiological | 2 | 2011 | 476 | 0.150 |
Why?
|
Antibodies | 2 | 2020 | 2416 | 0.150 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 257 | 0.150 |
Why?
|
Genes, BRCA2 | 3 | 2017 | 604 | 0.150 |
Why?
|
Gene Expression Regulation | 7 | 2017 | 11903 | 0.150 |
Why?
|
Cholangiocarcinoma | 2 | 2014 | 546 | 0.140 |
Why?
|
Evolution, Molecular | 2 | 2022 | 1883 | 0.140 |
Why?
|
Bile Duct Neoplasms | 2 | 2014 | 601 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 203 | 0.140 |
Why?
|
Piperazines | 4 | 2020 | 2516 | 0.140 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 600 | 0.140 |
Why?
|
Receptors, Steroid | 1 | 2017 | 153 | 0.140 |
Why?
|
Up-Regulation | 3 | 2008 | 4123 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1074 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2019 | 346 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 2 | 2019 | 1114 | 0.140 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 287 | 0.130 |
Why?
|
Estrogens | 1 | 2023 | 1520 | 0.130 |
Why?
|
Aneuploidy | 1 | 2020 | 551 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 824 | 0.130 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 414 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1287 | 0.130 |
Why?
|
Cytomegalovirus | 1 | 2020 | 757 | 0.130 |
Why?
|
Multiprotein Complexes | 2 | 2012 | 1121 | 0.120 |
Why?
|
Pyrimidinones | 1 | 2017 | 383 | 0.120 |
Why?
|
Heredity | 1 | 2015 | 148 | 0.120 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2017 | 273 | 0.120 |
Why?
|
Middle Aged | 21 | 2024 | 219628 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2620 | 0.120 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 429 | 0.120 |
Why?
|
DNA Repair | 1 | 2024 | 2039 | 0.120 |
Why?
|
Cadherins | 1 | 2019 | 897 | 0.120 |
Why?
|
Genotype | 9 | 2021 | 12940 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 3 | 2023 | 5637 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4492 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2016 | 2867 | 0.120 |
Why?
|
Androgen Antagonists | 1 | 2023 | 1443 | 0.110 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2014 | 298 | 0.110 |
Why?
|
Glioma | 3 | 2014 | 3414 | 0.110 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2225 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2012 | 18937 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2017 | 366 | 0.110 |
Why?
|
Adipocytes | 1 | 2020 | 1179 | 0.110 |
Why?
|
Neoadjuvant Therapy | 6 | 2023 | 2810 | 0.110 |
Why?
|
Piperidines | 1 | 2022 | 1648 | 0.110 |
Why?
|
Cell Differentiation | 6 | 2018 | 11461 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 21892 | 0.110 |
Why?
|
Brain Neoplasms | 4 | 2019 | 8950 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2014 | 2052 | 0.110 |
Why?
|
Adult | 18 | 2024 | 219353 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2011 | 1125 | 0.110 |
Why?
|
Fibroblast Growth Factor 7 | 1 | 2013 | 59 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9066 | 0.110 |
Why?
|
Sirtuins | 2 | 2021 | 320 | 0.110 |
Why?
|
Protein Biosynthesis | 4 | 2011 | 2118 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2020 | 5423 | 0.110 |
Why?
|
Hepatoblastoma | 1 | 2013 | 88 | 0.110 |
Why?
|
STAT5 Transcription Factor | 1 | 2014 | 265 | 0.110 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1343 | 0.110 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 101 | 0.110 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2015 | 243 | 0.110 |
Why?
|
Models, Biological | 5 | 2019 | 9460 | 0.100 |
Why?
|
Pyridones | 1 | 2017 | 787 | 0.100 |
Why?
|
Prognosis | 6 | 2019 | 29559 | 0.100 |
Why?
|
Genomics | 2 | 2021 | 5778 | 0.100 |
Why?
|
Blotting, Western | 3 | 2016 | 5039 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 244 | 0.100 |
Why?
|
Fatty Acids | 1 | 2020 | 1804 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2019 | 1522 | 0.100 |
Why?
|
Transfection | 4 | 2012 | 5781 | 0.100 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2019 | 1092 | 0.100 |
Why?
|
Genetic Counseling | 1 | 2015 | 625 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2017 | 2448 | 0.100 |
Why?
|
California | 1 | 2015 | 1403 | 0.100 |
Why?
|
Osteosarcoma | 2 | 2016 | 898 | 0.090 |
Why?
|
Receptor, erbB-2 | 3 | 2010 | 2524 | 0.090 |
Why?
|
Aged | 16 | 2024 | 168615 | 0.090 |
Why?
|
Genomic Instability | 1 | 2015 | 705 | 0.090 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 1994 | 0.090 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 1991 | 164 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2010 | 504 | 0.090 |
Why?
|
Carcinosarcoma | 1 | 2010 | 104 | 0.090 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 191 | 0.090 |
Why?
|
Milk Proteins | 1 | 2010 | 163 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2015 | 815 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2012 | 482 | 0.090 |
Why?
|
Gene Deletion | 2 | 2016 | 2666 | 0.090 |
Why?
|
Carcinoma | 1 | 2021 | 2335 | 0.090 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2015 | 3772 | 0.080 |
Why?
|
Disease Progression | 3 | 2023 | 13470 | 0.080 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 673 | 0.080 |
Why?
|
Alphapapillomavirus | 1 | 2012 | 218 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3618 | 0.080 |
Why?
|
Pharmacogenetics | 1 | 2013 | 680 | 0.080 |
Why?
|
Cell Lineage | 1 | 2018 | 2522 | 0.080 |
Why?
|
RNA, Messenger | 7 | 2016 | 12765 | 0.080 |
Why?
|
Antigens, CD | 1 | 2019 | 3916 | 0.080 |
Why?
|
Drug Synergism | 1 | 2012 | 1752 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2001 | 3384 | 0.080 |
Why?
|
Gene Frequency | 1 | 2015 | 3603 | 0.080 |
Why?
|
Telomerase | 3 | 1998 | 747 | 0.080 |
Why?
|
Cell Transformation, Viral | 1 | 2010 | 526 | 0.080 |
Why?
|
Trachea | 1 | 2014 | 1081 | 0.080 |
Why?
|
Fibroblasts | 3 | 2010 | 4085 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 1945 | 0.080 |
Why?
|
Antioxidants | 2 | 2021 | 1666 | 0.080 |
Why?
|
Genes, ras | 1 | 2010 | 654 | 0.080 |
Why?
|
Stomach Neoplasms | 1 | 2018 | 1422 | 0.070 |
Why?
|
Pedigree | 1 | 2015 | 4572 | 0.070 |
Why?
|
Point Mutation | 1 | 2013 | 1594 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1655 | 0.070 |
Why?
|
Benzamides | 1 | 2013 | 1369 | 0.070 |
Why?
|
Monomeric GTP-Binding Proteins | 2 | 2006 | 200 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4563 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4893 | 0.070 |
Why?
|
DNA Methylation | 4 | 2019 | 4371 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3482 | 0.070 |
Why?
|
Lung Neoplasms | 3 | 2018 | 13243 | 0.070 |
Why?
|
Gene Expression Profiling | 4 | 2015 | 9372 | 0.070 |
Why?
|
Ascorbic Acid | 1 | 2010 | 655 | 0.070 |
Why?
|
Organogenesis | 1 | 2008 | 215 | 0.070 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3443 | 0.070 |
Why?
|
Antigens, Surface | 1 | 2010 | 1607 | 0.070 |
Why?
|
Anoikis | 1 | 2006 | 49 | 0.070 |
Why?
|
Blotting, Northern | 2 | 2002 | 1545 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 699 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2017 | 11125 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4523 | 0.070 |
Why?
|
Telemedicine | 1 | 2023 | 2997 | 0.070 |
Why?
|
Women's Health | 1 | 2016 | 2057 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2010 | 673 | 0.070 |
Why?
|
Animals, Newborn | 1 | 2011 | 2673 | 0.070 |
Why?
|
Genes, bcl-2 | 1 | 2006 | 119 | 0.060 |
Why?
|
In Situ Hybridization | 3 | 2010 | 1899 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 358 | 0.060 |
Why?
|
Genital Neoplasms, Female | 1 | 2010 | 538 | 0.060 |
Why?
|
Cell Line | 4 | 2020 | 15638 | 0.060 |
Why?
|
Protein Binding | 4 | 2017 | 9334 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1122 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2015 | 2750 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1152 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2001 | 10069 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 717 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2002 | 4170 | 0.060 |
Why?
|
Glucose | 2 | 2020 | 4362 | 0.060 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2013 | 0.060 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 4922 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3481 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2016 | 2532 | 0.060 |
Why?
|
Transduction, Genetic | 1 | 2006 | 897 | 0.060 |
Why?
|
Binding Sites | 2 | 2010 | 6054 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4715 | 0.050 |
Why?
|
Rad51 Recombinase | 1 | 2024 | 189 | 0.050 |
Why?
|
Cell Size | 1 | 2005 | 622 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2005 | 3604 | 0.050 |
Why?
|
Hedgehog Proteins | 1 | 2008 | 769 | 0.050 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2009 | 491 | 0.050 |
Why?
|
Neuropeptides | 2 | 2006 | 941 | 0.050 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 2519 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 1989 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2019 | 9271 | 0.050 |
Why?
|
Sirolimus | 1 | 2010 | 1537 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9274 | 0.050 |
Why?
|
Hematopoiesis | 2 | 2002 | 2060 | 0.050 |
Why?
|
RNA Splicing | 1 | 2007 | 915 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2582 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 1991 | 2821 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9131 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 815 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3599 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3722 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2486 | 0.050 |
Why?
|
Molecular Biology | 2 | 2012 | 581 | 0.050 |
Why?
|
beta-Galactosidase | 1 | 2002 | 574 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 631 | 0.050 |
Why?
|
Sterol Esterase | 1 | 2020 | 40 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2413 | 0.050 |
Why?
|
DNA | 3 | 2024 | 7235 | 0.050 |
Why?
|
Aged, 80 and over | 5 | 2019 | 58864 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2218 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2020 | 64867 | 0.050 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 126 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1604 | 0.050 |
Why?
|
Xenopus | 1 | 2002 | 714 | 0.040 |
Why?
|
3T3-L1 Cells | 1 | 2020 | 209 | 0.040 |
Why?
|
Starvation | 1 | 2020 | 140 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1601 | 0.040 |
Why?
|
Cognition | 1 | 2018 | 6939 | 0.040 |
Why?
|
Oncogenes | 2 | 2014 | 1221 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2009 | 2560 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3518 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2016 | 1702 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2020 | 6814 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2006 | 3091 | 0.040 |
Why?
|
RNA | 3 | 1998 | 2719 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4006 | 0.040 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2024 | 608 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2002 | 1167 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15262 | 0.040 |
Why?
|
Dexamethasone | 1 | 2006 | 1927 | 0.040 |
Why?
|
Down-Regulation | 2 | 2004 | 2914 | 0.040 |
Why?
|
Risk Assessment | 2 | 2022 | 24049 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2008 | 1709 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6531 | 0.040 |
Why?
|
Drosophila Proteins | 1 | 2008 | 1698 | 0.040 |
Why?
|
Retroviridae | 1 | 2001 | 850 | 0.040 |
Why?
|
Adenoviridae | 1 | 2002 | 1084 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 3 | 2014 | 6530 | 0.040 |
Why?
|
Glutathione | 1 | 2021 | 582 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12896 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2756 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3960 | 0.040 |
Why?
|
Cell Cycle | 1 | 2006 | 2936 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2021 | 748 | 0.040 |
Why?
|
Cohort Studies | 3 | 2017 | 41266 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2019 | 327 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2002 | 13439 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2023 | 80125 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 489 | 0.040 |
Why?
|
Aerobiosis | 1 | 2017 | 101 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 2012 | 6070 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4313 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2002 | 1078 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2013 | 4429 | 0.040 |
Why?
|
Risk Factors | 4 | 2020 | 74167 | 0.040 |
Why?
|
Endoderm | 1 | 2018 | 155 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 392 | 0.040 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
Phosphorylation | 2 | 2005 | 8312 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2014 | 2499 | 0.040 |
Why?
|
Muscle Fatigue | 1 | 2017 | 93 | 0.040 |
Why?
|
Base Sequence | 2 | 2002 | 12442 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2002 | 17611 | 0.030 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2017 | 165 | 0.030 |
Why?
|
E2F Transcription Factors | 1 | 2017 | 269 | 0.030 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 1998 | 114 | 0.030 |
Why?
|
Corticosterone | 1 | 2017 | 303 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 635 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6312 | 0.030 |
Why?
|
Purines | 1 | 2019 | 602 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2021 | 858 | 0.030 |
Why?
|
Gene Expression | 3 | 2001 | 7583 | 0.030 |
Why?
|
Immunomodulation | 1 | 2020 | 548 | 0.030 |
Why?
|
Fluorouracil | 1 | 2020 | 1621 | 0.030 |
Why?
|
Receptors, Glucocorticoid | 1 | 2017 | 296 | 0.030 |
Why?
|
Aminopyridines | 1 | 2019 | 564 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 1998 | 458 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10181 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 2651 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3523 | 0.030 |
Why?
|
Gene Amplification | 1 | 2019 | 1085 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1708 | 0.030 |
Why?
|
RNA, Untranslated | 1 | 1998 | 459 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 748 | 0.030 |
Why?
|
Cytosol | 1 | 2017 | 887 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 1999 | 1248 | 0.030 |
Why?
|
Pregnancy | 2 | 2014 | 29650 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2001 | 2698 | 0.030 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2021 | 1615 | 0.030 |
Why?
|
Hydrogels | 1 | 2019 | 725 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2020 | 937 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2001 | 2419 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2020 | 1342 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 352 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1588 | 0.030 |
Why?
|
Male | 15 | 2019 | 358602 | 0.030 |
Why?
|
Embryonic Development | 1 | 2018 | 713 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5247 | 0.030 |
Why?
|
Leukemia | 1 | 2001 | 1511 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2018 | 3600 | 0.030 |
Why?
|
Tissue Scaffolds | 1 | 2019 | 926 | 0.030 |
Why?
|
Adult Children | 1 | 2013 | 103 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8530 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2388 | 0.030 |
Why?
|
Nuclear Family | 1 | 2013 | 312 | 0.020 |
Why?
|
Survival Rate | 2 | 2018 | 12793 | 0.020 |
Why?
|
Monocytes | 1 | 2001 | 2568 | 0.020 |
Why?
|
Mammography | 1 | 2022 | 2449 | 0.020 |
Why?
|
Young Adult | 5 | 2019 | 58477 | 0.020 |
Why?
|
Genetic Markers | 1 | 1998 | 2607 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2001 | 3376 | 0.020 |
Why?
|
Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
3T3 Cells | 2 | 2004 | 1085 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 1998 | 979 | 0.020 |
Why?
|
Receptors, Vitronectin | 1 | 2010 | 48 | 0.020 |
Why?
|
Restriction Mapping | 1 | 1991 | 852 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1512 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 1998 | 1787 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1991 | 311 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 515 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2023 | 3598 | 0.020 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2012 | 428 | 0.020 |
Why?
|
Integrin alphaVbeta3 | 1 | 2010 | 105 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 1 | 2020 | 1439 | 0.020 |
Why?
|
Brain | 2 | 2019 | 26860 | 0.020 |
Why?
|
Metformin | 1 | 2017 | 912 | 0.020 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1991 | 534 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2010 | 186 | 0.020 |
Why?
|
Cell Respiration | 1 | 2010 | 202 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1494 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1738 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1991 | 500 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2017 | 2912 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 1991 | 497 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 1362 | 0.020 |
Why?
|
Astrocytoma | 1 | 2013 | 775 | 0.020 |
Why?
|
Oligonucleotides | 1 | 1991 | 589 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2022 | 3203 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1618 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1991 | 796 | 0.020 |
Why?
|
Parapsoriasis | 1 | 1987 | 2 | 0.020 |
Why?
|
Morphogenesis | 1 | 1991 | 740 | 0.020 |
Why?
|
Pityriasis | 1 | 1987 | 11 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2013 | 1166 | 0.020 |
Why?
|
Pyridines | 1 | 2019 | 2876 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2009 | 410 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1740 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2008 | 183 | 0.020 |
Why?
|
Growth Inhibitors | 1 | 2008 | 377 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 611 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3812 | 0.020 |
Why?
|
Catalysis | 2 | 1998 | 775 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 25853 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 784 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2012 | 1358 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 1991 | 1388 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5310 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1045 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2020 | 3216 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8465 | 0.020 |
Why?
|
Testis | 2 | 1999 | 794 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1991 | 1772 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2524 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 749 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3153 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 2009 | 8548 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5196 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3272 | 0.010 |
Why?
|
Species Specificity | 1 | 2008 | 2408 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 2008 | 704 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5690 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8435 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 2001 | 73 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 21992 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8788 | 0.010 |
Why?
|
Genome, Human | 1 | 2014 | 4412 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12526 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 2001 | 148 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18391 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2801 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2001 | 6538 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10329 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11046 | 0.010 |
Why?
|
Luciferases | 1 | 2001 | 717 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1999 | 451 | 0.010 |
Why?
|
Zinc Fingers | 1 | 2001 | 568 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15639 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9501 | 0.010 |
Why?
|
Rats | 2 | 2006 | 23577 | 0.010 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 444 | 0.010 |
Why?
|
HL-60 Cells | 1 | 1998 | 363 | 0.010 |
Why?
|
Cell Division | 1 | 2004 | 4445 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2006 | 2142 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21344 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2003 | 2218 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2001 | 1532 | 0.010 |
Why?
|
Gene Library | 1 | 1999 | 1060 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16524 | 0.010 |
Why?
|
Doxorubicin | 1 | 2003 | 2202 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39213 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 8050 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1998 | 1432 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2006 | 8147 | 0.010 |
Why?
|
Paclitaxel | 1 | 2003 | 1716 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4409 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1665 | 0.010 |
Why?
|
Adolescent | 2 | 2013 | 87551 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1997 | 2176 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 41932 | 0.010 |
Why?
|
Protein Conformation | 1 | 1997 | 3969 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4625 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1987 | 553 | 0.000 |
Why?
|
Kidney | 1 | 2001 | 7028 | 0.000 |
Why?
|
Child | 1 | 2011 | 79604 | 0.000 |
Why?
|
Lymphoproliferative Disorders | 1 | 1987 | 532 | 0.000 |
Why?
|